Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hubei
Clinical trial register · China

Clinical Trials in Hubei, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Hubei 2 Shanghai 2 Hefei 1 Fuzhou 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca2 Sinovac Biotech Co., Ltd2 Astellas Pharma Global Development, Inc.2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2 Beijing Continent Pharmaceutical Co, Ltd.2 Genmab1 Hospital of Stomatology, Wuhan University1 DualityBio Inc.1 Telix Pharmaceuticals (Innovations) Pty Limited1 Daishi Tian1 Xiangyang No.1 People's Hospital1 Tongji Hospital1 UCARsgen Biotech Limited1 Shenzhen Majory Biotechnology Co., Ltd.1 Abbisko Therapeutics Co, Ltd1 Haihe Biopharma Co., Ltd.1 Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.1 Beijing BeneWill Technology Development Co., Ltd1 Qian Chu1 Daiichi Sankyo1 Clear sponsor filter
Site location
Beijing4 Hubei2 Shanghai2 Hefei1 Fuzhou1 Lanzhou1 Foshan1 Guangzhou1 Maoming1 Shenzhen1 Qingyuan1 Shiyan1 Huaihua1 Pingxiang1 Changchun1 Binzhou1 Heze1 Bengbu1 Changsha1 Chongqing1 Guizhou1 Hangzhou1 Henan1
All 23 locations
Target enrolment
to

Trials with a site in Hubei

2 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Beijing Continent Pharmaceutical Co, Ltd.
Phase 1
56
Hubei
2025-12-25
Recruiting
Preliminary Human Trials of F230 Tablets
NCT06899815Pulmonary Hypertension
Beijing Continent Pharmaceutical Co, Ltd.
Phase 1
136
Hubei
2025-05-15
Rows per page Showing 1–2 of 2
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/hubei

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2 of those studies with a site in Hubei that also match the filters currently applied.

How many clinical trials are recruiting in Hubei?

2 of the 2 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hubei), 2 studies
PhaseStudiesRecruitingShare
Phase 122100%

Most active sponsors

Lead sponsors with the most studies (Hubei)
Lead sponsorStudiesRecruiting
Beijing Continent Pharmaceutical Co, Ltd.22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.